Table of Content

1 Inhaled NO Vasodilator Market Overview
1.1 Product Overview and Scope of Inhaled NO Vasodilator
1.2 Inhaled NO Vasodilator Segment by Type
1.2.1 Global Inhaled NO Vasodilator Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Others
1.3 Inhaled NO Vasodilator Segment by Application
1.3.1 Inhaled NO Vasodilator Sales Comparison by Application: (2021-2027)
1.3.2 PPHN
1.3.3 ARDS
1.3.4 Others
1.4 Global Inhaled NO Vasodilator Market Size Estimates and Forecasts
1.4.1 Global Inhaled NO Vasodilator Revenue 2016-2027
1.4.2 Global Inhaled NO Vasodilator Sales 2016-2027
1.4.3 Inhaled NO Vasodilator Market Size by Region: 2016 Versus 2021 Versus 2027

2 Inhaled NO Vasodilator Market Competition by Manufacturers
2.1 Global Inhaled NO Vasodilator Sales Market Share by Manufacturers (2016-2021)
2.2 Global Inhaled NO Vasodilator Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Inhaled NO Vasodilator Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Inhaled NO Vasodilator Manufacturing Sites, Area Served, Product Type
2.5 Inhaled NO Vasodilator Market Competitive Situation and Trends
2.5.1 Inhaled NO Vasodilator Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Inhaled NO Vasodilator Players Market Share by Revenue
2.5.3 Global Inhaled NO Vasodilator Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Inhaled NO Vasodilator Retrospective Market Scenario by Region
3.1 Global Inhaled NO Vasodilator Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Inhaled NO Vasodilator Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Inhaled NO Vasodilator Market Facts & Figures by Country
3.3.1 North America Inhaled NO Vasodilator Sales by Country
3.3.2 North America Inhaled NO Vasodilator Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Inhaled NO Vasodilator Market Facts & Figures by Country
3.4.1 Europe Inhaled NO Vasodilator Sales by Country
3.4.2 Europe Inhaled NO Vasodilator Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Inhaled NO Vasodilator Market Facts & Figures by Region
3.5.1 Asia Pacific Inhaled NO Vasodilator Sales by Region
3.5.2 Asia Pacific Inhaled NO Vasodilator Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Inhaled NO Vasodilator Market Facts & Figures by Country
3.6.1 Latin America Inhaled NO Vasodilator Sales by Country
3.6.2 Latin America Inhaled NO Vasodilator Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Inhaled NO Vasodilator Market Facts & Figures by Country
3.7.1 Middle East and Africa Inhaled NO Vasodilator Sales by Country
3.7.2 Middle East and Africa Inhaled NO Vasodilator Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Inhaled NO Vasodilator Historic Market Analysis by Type
4.1 Global Inhaled NO Vasodilator Sales Market Share by Type (2016-2021)
4.2 Global Inhaled NO Vasodilator Revenue Market Share by Type (2016-2021)
4.3 Global Inhaled NO Vasodilator Price by Type (2016-2021)

5 Global Inhaled NO Vasodilator Historic Market Analysis by Application
5.1 Global Inhaled NO Vasodilator Sales Market Share by Application (2016-2021)
5.2 Global Inhaled NO Vasodilator Revenue Market Share by Application (2016-2021)
5.3 Global Inhaled NO Vasodilator Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Mallinckrodt
6.1.1 Mallinckrodt Corporation Information
6.1.2 Mallinckrodt Description and Business Overview
6.1.3 Mallinckrodt Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Mallinckrodt Product Portfolio
6.1.5 Mallinckrodt Recent Developments/Updates
6.2 Praxair (Linde plc)
6.2.1 Praxair (Linde plc) Corporation Information
6.2.2 Praxair (Linde plc) Description and Business Overview
6.2.3 Praxair (Linde plc) Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Praxair (Linde plc) Product Portfolio
6.2.5 Praxair (Linde plc) Recent Developments/Updates
6.3 Air Liquide
6.3.1 Air Liquide Corporation Information
6.3.2 Air Liquide Description and Business Overview
6.3.3 Air Liquide Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Air Liquide Product Portfolio
6.3.5 Air Liquide Recent Developments/Updates
6.4 BOC Healthcare (Linde Group)
6.4.1 BOC Healthcare (Linde Group) Corporation Information
6.4.2 BOC Healthcare (Linde Group) Description and Business Overview
6.4.3 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BOC Healthcare (Linde Group) Product Portfolio
6.4.5 BOC Healthcare (Linde Group) Recent Developments/Updates

7 Inhaled NO Vasodilator Manufacturing Cost Analysis
7.1 Inhaled NO Vasodilator Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Inhaled NO Vasodilator
7.4 Inhaled NO Vasodilator Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Inhaled NO Vasodilator Distributors List
8.3 Inhaled NO Vasodilator Customers

9 Inhaled NO Vasodilator Market Dynamics
9.1 Inhaled NO Vasodilator Industry Trends
9.2 Inhaled NO Vasodilator Growth Drivers
9.3 Inhaled NO Vasodilator Market Challenges
9.4 Inhaled NO Vasodilator Market Restraints

10 Global Market Forecast
10.1 Inhaled NO Vasodilator Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Inhaled NO Vasodilator by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Inhaled NO Vasodilator by Type (2022-2027)
10.2 Inhaled NO Vasodilator Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Inhaled NO Vasodilator by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Inhaled NO Vasodilator by Application (2022-2027)
10.3 Inhaled NO Vasodilator Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Inhaled NO Vasodilator by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Inhaled NO Vasodilator by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Inhaled NO Vasodilator Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Inhaled NO Vasodilator Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Inhaled NO Vasodilator Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Inhaled NO Vasodilator Covered in This Study
Table 5. Global Inhaled NO Vasodilator Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Inhaled NO Vasodilator Sales Share by Manufacturers (2016-2021)
Table 7. Global Inhaled NO Vasodilator Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Inhaled NO Vasodilator Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Inhaled NO Vasodilator Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Inhaled NO Vasodilator Manufacturing Sites and Area Served
Table 11. Manufacturers Inhaled NO Vasodilator Product Type
Table 12. Global Inhaled NO Vasodilator Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Inhaled NO Vasodilator by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhaled NO Vasodilator as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Inhaled NO Vasodilator Sales by Region (2016-2021) & (K Units)
Table 16. Global Inhaled NO Vasodilator Sales Market Share by Region (2016-2021)
Table 17. Global Inhaled NO Vasodilator Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Inhaled NO Vasodilator Sales by Country (2016-2021) & (K Units)
Table 19. North America Inhaled NO Vasodilator Sales Market Share by Country (2016-2021)
Table 20. North America Inhaled NO Vasodilator Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Inhaled NO Vasodilator Revenue Market Share by Country (2016-2021)
Table 22. Europe Inhaled NO Vasodilator Sales by Country (2016-2021) & (K Units)
Table 23. Europe Inhaled NO Vasodilator Sales Market Share by Country (2016-2021)
Table 24. Europe Inhaled NO Vasodilator Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Inhaled NO Vasodilator Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Inhaled NO Vasodilator Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Inhaled NO Vasodilator Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Inhaled NO Vasodilator Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Inhaled NO Vasodilator Revenue Market Share by Region (2016-2021)
Table 30. Latin America Inhaled NO Vasodilator Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Inhaled NO Vasodilator Sales Market Share by Country (2016-2021)
Table 32. Latin America Inhaled NO Vasodilator Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Inhaled NO Vasodilator Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Inhaled NO Vasodilator Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Inhaled NO Vasodilator Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Inhaled NO Vasodilator Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Inhaled NO Vasodilator Revenue Market Share by Country (2016-2021)
Table 38. Global Inhaled NO Vasodilator Sales (K Units) by Type (2016-2021)
Table 39. Global Inhaled NO Vasodilator Sales Market Share by Type (2016-2021)
Table 40. Global Inhaled NO Vasodilator Revenue (Million US$) by Type (2016-2021)
Table 41. Global Inhaled NO Vasodilator Revenue Share by Type (2016-2021)
Table 42. Global Inhaled NO Vasodilator Price (US$/Unit) by Type (2016-2021)
Table 43. Global Inhaled NO Vasodilator Sales (K Units) by Application (2016-2021)
Table 44. Global Inhaled NO Vasodilator Sales Market Share by Application (2016-2021)
Table 45. Global Inhaled NO Vasodilator Revenue (Million US$) by Application (2016-2021)
Table 46. Global Inhaled NO Vasodilator Revenue Share by Application (2016-2021)
Table 47. Global Inhaled NO Vasodilator Price (US$/Unit) by Application (2016-2021)
Table 48. Mallinckrodt Corporation Information
Table 49. Mallinckrodt Description and Business Overview
Table 50. Mallinckrodt Inhaled NO Vasodilator Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Mallinckrodt Inhaled NO Vasodilator Product
Table 52. Mallinckrodt Recent Developments/Updates
Table 53. Praxair (Linde plc) Corporation Information
Table 54. Praxair (Linde plc) Description and Business Overview
Table 55. Praxair (Linde plc) Inhaled NO Vasodilator Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Praxair (Linde plc) Inhaled NO Vasodilator Product
Table 57. Praxair (Linde plc) Recent Developments/Updates
Table 58. Air Liquide Corporation Information
Table 59. Air Liquide Description and Business Overview
Table 60. Air Liquide Inhaled NO Vasodilator Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Air Liquide Inhaled NO Vasodilator Product
Table 62. Air Liquide Recent Developments/Updates
Table 63. BOC Healthcare (Linde Group) Corporation Information
Table 64. BOC Healthcare (Linde Group) Description and Business Overview
Table 65. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product
Table 67. BOC Healthcare (Linde Group) Recent Developments/Updates
Table 68. Production Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Inhaled NO Vasodilator Distributors List
Table 71. Inhaled NO Vasodilator Customers List
Table 72. Inhaled NO Vasodilator Market Trends
Table 73. Inhaled NO Vasodilator Growth Drivers
Table 74. Inhaled NO Vasodilator Market Restraints
Table 75. Global Inhaled NO Vasodilator Sales Forecast by Type (2022-2027) & (K Units)
Table 76. Global Inhaled NO Vasodilator Sales Market Share Forecast by Type (2022-2027)
Table 77. Global Inhaled NO Vasodilator Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 78. Global Inhaled NO Vasodilator Revenue Market Share Forecast by Type (2022-2027)
Table 79. Global Inhaled NO Vasodilator Sales Forecast by Application (2022-2027) & (K Units)
Table 80. Global Inhaled NO Vasodilator Sales Market Share Forecast by Application (2022-2027)
Table 81. Global Inhaled NO Vasodilator Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 82. Global Inhaled NO Vasodilator Revenue Market Share Forecast by Application (2022-2027)
Table 83. Global Inhaled NO Vasodilator Sales Forecast by Region (2022-2027) & (K Units)
Table 84. Global Inhaled NO Vasodilator Sales Market Share Forecast by Region (2022-2027)
Table 85. Global Inhaled NO Vasodilator Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 86. Global Inhaled NO Vasodilator Revenue Market Share Forecast by Region (2022-2027)
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inhaled NO Vasodilator
Figure 2. Global Inhaled NO Vasodilator Market Share by Type in 2020 & 2027
Figure 3. 800 ppm Product Picture
Figure 4. 100 ppm Product Picture
Figure 5. Others Product Picture
Figure 6. Global Inhaled NO Vasodilator Market Share by Application in 2020 & 2027
Figure 7. PPHN
Figure 8. ARDS
Figure 9. Others
Figure 10. Global Inhaled NO Vasodilator Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Inhaled NO Vasodilator Market Size 2016-2027 (US$ Million)
Figure 12. Global Inhaled NO Vasodilator Sales 2016-2027 (K Units)
Figure 13. Global Inhaled NO Vasodilator Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Inhaled NO Vasodilator Sales Share by Manufacturers in 2020
Figure 15. Global Inhaled NO Vasodilator Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Inhaled NO Vasodilator Players: Market Share by Revenue in 2020
Figure 17. Inhaled NO Vasodilator Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Inhaled NO Vasodilator Sales Market Share by Region (2016-2021)
Figure 19. Global Inhaled NO Vasodilator Sales Market Share by Region in 2020
Figure 20. Global Inhaled NO Vasodilator Revenue Market Share by Region (2016-2021)
Figure 21. Global Inhaled NO Vasodilator Revenue Market Share by Region in 2020
Figure 22. U.S. Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Inhaled NO Vasodilator Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Inhaled NO Vasodilator by Type (2016-2021)
Figure 47. Sales Market Share of Inhaled NO Vasodilator by Application (2016-2021)
Figure 48. Sales Market Share of Inhaled NO Vasodilator by Application in 2020
Figure 49. Revenue Share of Inhaled NO Vasodilator by Application (2016-2021)
Figure 50. Revenue Share of Inhaled NO Vasodilator by Application in 2020
Figure 51. Manufacturing Cost Structure of Inhaled NO Vasodilator
Figure 52. Manufacturing Process Analysis of Inhaled NO Vasodilator
Figure 53. Inhaled NO Vasodilator Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed